Amy Sion to Antibodies, Monoclonal, Humanized
This is a "connection" page, showing publications Amy Sion has written about Antibodies, Monoclonal, Humanized.
Connection Strength
0.745
-
Immune-related adverse events are linked with improved progression-free survival in patients receiving anti-PD-1/PD-L1 therapy. Semin Oncol. 2018 06; 45(3):156-163.
Score: 0.594
-
Evaluation of arthralgias in adult oncology patients receiving immune checkpoint inhibitors. J Oncol Pharm Pract. 2019 Dec; 25(8):1867-1872.
Score: 0.151